"P-Selectin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.
| Descriptor ID |
D019007
|
| MeSH Number(s) |
D12.776.395.550.200.700.775 D12.776.395.550.625.905 D12.776.503.843.775 D12.776.543.550.200.700.775 D12.776.543.550.625.905 D23.050.301.350.700.775
|
| Concept/Terms |
P-Selectin- P-Selectin
- GMP-140
- P Selectin
- Selectin, P
- PADGEM
- CD62P Antigen
- Antigen, CD62P
- Antigens, CD62P
- CD62P Antigens
- Platelet alpha-Granule Membrane Protein
- Platelet alpha Granule Membrane Protein
- LECAM-3
|
Below are MeSH descriptors whose meaning is more general than "P-Selectin".
Below are MeSH descriptors whose meaning is more specific than "P-Selectin".
This graph shows the total number of publications written about "P-Selectin" by people in this website by year, and whether "P-Selectin" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 3 | 3 | 6 |
| 1997 | 3 | 2 | 5 |
| 1998 | 8 | 1 | 9 |
| 1999 | 1 | 1 | 2 |
| 2000 | 3 | 1 | 4 |
| 2001 | 4 | 3 | 7 |
| 2002 | 8 | 2 | 10 |
| 2003 | 3 | 4 | 7 |
| 2004 | 3 | 3 | 6 |
| 2005 | 4 | 7 | 11 |
| 2006 | 0 | 6 | 6 |
| 2007 | 3 | 3 | 6 |
| 2008 | 4 | 2 | 6 |
| 2009 | 1 | 6 | 7 |
| 2010 | 3 | 5 | 8 |
| 2011 | 1 | 6 | 7 |
| 2012 | 4 | 2 | 6 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2015 | 4 | 4 | 8 |
| 2016 | 1 | 5 | 6 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 3 | 4 | 7 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 4 | 3 | 7 |
Below are the most recent publications written about "P-Selectin" by people in Profiles.
-
P-selectin-dependent leukocyte adhesion is governed by endolysosomal two-pore channel 2. Cell Rep. 2023 12 26; 42(12):113501.
-
Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy. Am J Transplant. 2024 Mar; 24(3):406-418.
-
Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand. Cells. 2023 09 13; 12(18).
-
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial. Circulation. 2023 08; 148(5):381-390.
-
Associations of Microvascular Injury-Related Biomarkers With Traumatic Brain Injury Severity and Outcomes: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot Study. J Neurotrauma. 2023 08; 40(15-16):1625-1637.
-
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life Sci Alliance. 2023 07; 6(7).
-
Inflammatory biomarkers and MRI visible perivascular spaces: The Framingham Heart Study. Neurobiol Aging. 2023 07; 127:12-22.
-
Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells. J Immunol. 2022 10 01; 209(7):1359-1369.
-
Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus. AIDS. 2022 11 01; 36(13):1801-1809.
-
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol. 2021 11; 195(4):e150-e153.